{"paper_id":"925b69cd-d3fc-4dee-ad40-b08e63df8214","body_text":"Abstract\nThe uterine cavity was formerly considered sterile; however, over recent years, researchers have identified the presence of endometrial microbiota. An imbalance in the endometrial microbiota, or dysbiosis, has been shown to be associated with a variety of gynecological diseases. Endometriosis (EM) is a chronic and inflammatory gynecological disease that affects 6–10% of all women of reproductive-age. Previous studies suggested that endometrial dysbiosis can participate in the development of EM by generating an inflammatory state, leading to disorders of immune homeostasis and thus creating an intrauterine environment conducive to endometrial stromal cell migration and adhesion. In this review, we investigate differences in the endometrial microbiota of patients with EM compared with that of healthy women and discuss the possible pathogenic mechanisms responsible for endometrial dysbiosis. Critically, we identified that an increase of lipopolysaccharides resulting from microbiological disorders may generate chronic inflammation, leading to increased adhesion and angiogenesis, and the development of EM. The findings of our review may identify new therapeutic strategies and potential therapeutic targets for EM.\nSimilar content being viewed by others\nData Availability\nAll data generated or analyzed during this study are included in this published article. Additional information is available from the corresponding author upon reasonable request.\nReferences\nTaylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397:839–52. https://doi.org/10.1016/S0140-6736(21)00389-5.\nMaruyama S, Imanaka S, Nagayasu M, Kimura M, Kobayashi H. Relationship between adenomyosis and endometriosis; different phenotypes of a single disease? Eur J Obstet Gynecol Reprod Biol. 2020;253:191–7. https://doi.org/10.1016/j.ejogrb.2020.08.019.\nMøller BR, Kristiansen FV, Thorsen P, Frost L, Mogensen SC. Sterility of the uterine cavity. Acta Obstet Gynecol Scand. 1995;74:216–9. https://doi.org/10.3109/00016349509008942.\nBaker JM, Chase DM, Herbst-Kralovetz MM. Uterine microbiota: Residents, Tourists, or invaders? Front Immunol. 2018;9:208. https://doi.org/10.3389/fimmu.2018.00208.\nMedina-Bastidas D, Camacho-Arroyo I, García-Gómez E. Current findings in endometrial microbiome: impact on uterine diseases. Reproduction. 2022;163:R81–96. https://doi.org/10.1530/REP-21-0120.\nMitchell CM, Haick A, Nkwopara E, Garcia R, Rendi M, Agnew K, et al. Colonization of the upper genital tract by vaginal bacterial species in nonpregnant women. Am J Obstet Gynecol. 2015;212:611. https://doi.org/10.1016/j.ajog.2014.11.043.e1-611.e9.\nMoreno I, Codoñer FM, Vilella F, Valbuena D, Martinez-Blanch JF, Jimenez-Almazán J, et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol. 2016;215:684–703. https://doi.org/10.1016/j.ajog.2016.09.075.\nTao X, Franasiak JM, Zhan Y, Scott RT, Rajchel J, Bedard J, et al. Characterizing the endometrial Microbiome by analyzing the ultra-low bacteria from embryo transfer catheter tips in IVF cycles: next generation sequencing (NGS) analysis of the 16S ribosomal gene. Hum Microbiome J. 2017;3:15–21. https://doi.org/10.1016/j.humic.2017.01.004.\nMiles SM, Hardy BL, Merrell DS. Investigation of the microbiota of the reproductive tract in women undergoing a total hysterectomy and bilateral salpingo-oopherectomy. Fertil Steril. 2017;107:813-820.e1. https://doi.org/10.1016/j.fertnstert.2016.11.028.\nKyono K, Hashimoto T, Nagai Y, Sakuraba Y. Analysis of endometrial microbiota by 16S ribosomal RNA gene sequencing among infertile patients: a single-center pilot study. Reprod Med Biol. 2018;17:297–306. https://doi.org/10.1002/rmb2.12105.\nCarosso A, Revelli A, Gennarelli G, Canosa S, Cosma S, Borella F, et al. Controlled ovarian stimulation and progesterone supplementation affect vaginal and endometrial microbiota in IVF cycles: a pilot study. J Assist Reprod Genet. 2020;37:2315–26. https://doi.org/10.1007/s10815-020-01878-4.\nMoreno I, Garcia-Grau I, Perez-Villaroya D, Gonzalez-Monfort M, Bahçeci M, Barrionuevo MJ, et al. Endometrial microbiota composition is associated with reproductive outcome in infertile patients. Microbiome. 2022;10:1. https://doi.org/10.1186/s40168-021-01184-w.\nVerstraelen H, Vilchez-Vargas R, Desimpel F, Jauregui R, Vankeirsbilck N, Weyers S, et al. Characterisation of the human uterine microbiome in non-pregnant women through deep sequencing of the V1-2 region of the 16S rRNA gene. PeerJ. 2016;4:e1602. https://doi.org/10.7717/peerj.1602.\nChen C, Song X, Wei W, Zhong H, Dai J, Lan Z, et al. The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat Commun. 2017;8:875. https://doi.org/10.1038/s41467-017-00901-0.\nLi F, Chen C, Wei W, Wang Z, Dai J, Hao L, et al. The metagenome of the female upper reproductive tract. Gigascience. 2018;7:giy107. https://doi.org/10.1093/gigascience/giy107.\nWinters A, Romero R, Gervasi M, Gomez-Lopez N, Tran MR, Garcia-Flores V, et al. Does the endometrial cavity have a molecular microbial signature? Sci Rep. 2019;9:9905. https://doi.org/10.1038/s41598-019-46173-0.\nLeoni C, Ceci O, Manzari C, Fosso B, Volpicella M, Ferrari A, et al. Human endometrial microbiota at term of normal pregnancies. Genes. 2019;10:971. https://doi.org/10.3390/genes10120971.\nSaunders PTK, Horne AW. Endometriosis: etiology, pathobiology, and therapeutic prospects. Cell. 2021;184:2807–24. https://doi.org/10.1016/j.cell.2021.04.041.\nKhan KN, Fujishita A, Hiraki K, Kitajima M, Nakashima M, Fushiki S, et al. Bacterial contamination hypothesis: a new concept in endometriosis. Reprod Med Biol. 2018;17:125–33. https://doi.org/10.1002/rmb2.12083.\nHan YW, Redline RW, Li M, Yin L, Hill GB, McCormick TS. Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect Immun. 2004;72:2272–9. https://doi.org/10.1128/IAI.72.4.2272-2279.2004.\nLindheim L, Bashir M, Münzker J, Trummer C, Zachhuber V, Leber B, et al. Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): a pilot study. PLoS One. 2017;12:e0168390. https://doi.org/10.1371/journal.pone.0168390.\nJeon SJ, Cunha F, Vieira-Neto A, Bicalho RC, Lima S, Bicalho ML, et al. Blood as a route of transmission of uterine pathogens from the gut to the uterus in cows. Microbiome. 2017;5:109. https://doi.org/10.1186/s40168-017-0328-9.\nKunz G, Leyendecker G. Uterine peristaltic activity during the menstrual cycle: characterization, regulation, function and dysfunction. Reprod Biomed Online. 2002;4(Suppl 3):5–9. https://doi.org/10.1016/s1472-6483(12)60108-4.\nHansen LK, Becher N, Bastholm S, Glavind J, Ramsing M, Kim CJ, et al. The cervical mucus plug inhibits, but does not block, the passage of ascending bacteria from the vagina during pregnancy. Acta Obstet Gynecol Scand. 2014;93:102–8. https://doi.org/10.1111/aogs.12296.\nWang J, Li Z, Ma X, Du L, Jia Z, Cui X, et al. Translocation of vaginal microbiota is involved in impairment and protection of uterine health. Nat Commun. 2021;12:4191. https://doi.org/10.1038/s41467-021-24516-8.\nPereira N, Hutchinson AP, Lekovich JP, Hobeika E, Elias RT. Antibiotic prophylaxis for gynecologic procedures prior to and during the utilization of assisted reproductive technologies: a systematic review. J Pathog. 2016;2016:4698314. https://doi.org/10.1155/2016/4698314.\nKhan KN, Kitajima M, Hiraki K, Yamaguchi N, Katamine S, Matsuyama T, et al. Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis. Fertil Steril. 2010;94:2860–3. https://doi.org/10.1016/j.fertnstert.2010.04.053. .e1-3.\nKhan KN, Fujishita A, Kitajima M, Hiraki K, Nakashima M, Masuzaki H. Intra-uterine microbial colonization and occurrence of endometritis in women with endometriosis. Hum Reprod. 2014;29:2446–56. https://doi.org/10.1093/humrep/deu222.\nKhan KN, Fujishita A, Masumoto H, Muto H, Kitajima M, Masuzaki H, et al. Molecular detection of intrauterine microbial colonization in women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2016;199:69–75. https://doi.org/10.1016/j.ejogrb.2016.01.040.\nWei W, Zhang X, Tang H, Zeng L, Wu R. Microbiota composition and distribution along the female reproductive tract of women with endometriosis. Ann Clin Microbiol Antimicrob. 2020;19:15. https://doi.org/10.1186/s12941-020-00356-0.\nWessels JM, Domínguez MA, Leyland NA, Agarwal SK, Foster WG. Endometrial microbiota is more diverse in people with endometriosis than symptomatic controls. Sci Rep. 2021;11:18877. https://doi.org/10.1038/s41598-021-98380-3.\nHu J, Li G, Huang M, Shen Q, Gu H, Xue N, et al. Analysis of microbiota reveals the underlying mechanism of PHF11 in the development of Enterococcus-regulated endometriotic cysts. iScience. 2023;26:108158. https://doi.org/10.1016/j.isci.2023.108158.\nMuraoka A, Suzuki M, Hamaguchi T, Watanabe S, Iijima K, Murofushi Y, et al. Fusobacterium infection facilitates the development of endometriosis through the phenotypic transition of endometrial fibroblasts. Sci Transl Med. 2023;15:eadd1531. https://doi.org/10.1126/scitranslmed.add1531.\nGuo W, Xu Z, Hu S, Shen Y. Exploring microbial signatures in endometrial tissues with endometriosis. Int Immunopharmacol. 2025;148:114072. https://doi.org/10.1016/j.intimp.2025.114072.\nCregger MA, Lenz K, Leary E, Leach R, Fazleabas A, White B et al. Reproductive microbiomes: using the Microbiome as a novel diagnostic tool for endometriosis. Reproductive Immunol Open Acc [Internet]. 2017 ;02. https://doi.org/10.21767/2476-1974.100036. [cited 2024 July 9]\nHernandes C, Silveira P, Rodrigues Sereia AF, Christoff AP, Mendes H, Valter De Oliveira LF, et al. Microbiome profile of deep endometriosis patients: comparison of vaginal fluid, endometrium and lesion. Diagnostics. 2020;10:163. https://doi.org/10.3390/diagnostics10030163.\nAkiyama K, Nishioka K, Khan KN, Tanaka Y, Mori T, Nakaya T, et al. Molecular detection of microbial colonization in cervical mucus of women with and without endometriosis. Am J Reprod Immunol. 2019;82:null. https://doi.org/10.1111/aji.13147.\nIba Y, Harada T, Horie S, Deura I, Iwabe T, Terakawa N. Lipopolysaccharide-promoted proliferation of endometriotic stromal cells via induction of tumor necrosis factor alpha and interleukin-8 expression. Fertil Steril. 2004;82(Suppl 3):1036–42. https://doi.org/10.1016/j.fertnstert.2004.04.038.\nToson B, Simon C, Moreno I. The endometrial microbiome and its impact on human conception. Int J Mol Sci. 2022;23:485. https://doi.org/10.3390/ijms23010485.\nKhan KN, Masuzaki H, Fujishita A, Kitajima M, Kohno T, Sekine I, et al. Regulation of hepatocyte growth factor by basal and stimulated macrophages in women with endometriosis. Hum Reprod. 2005;20:49–60. https://doi.org/10.1093/humrep/deh525.\nKhan KN, Kitajima M, Hiraki K, Fujishita A, Sekine I, Ishimaru T, et al. Immunopathogenesis of pelvic endometriosis: role of hepatocyte growth factor, macrophages and ovarian steroids. Am J Reprod Immunol. 2008;60:383–404. https://doi.org/10.1111/j.1600-0897.2008.00643.x.\nTakenaka Y, Taniguchi F, Miyakoda H, Takai E, Terakawa N, Harada T. Lipopolysaccharide promoted proliferation and invasion of endometriotic stromal cells via induction of cyclooxygenase-2 expression. Fertil Steril. 2010;93:325–7. https://doi.org/10.1016/j.fertnstert.2009.06.042.\nSampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol. 1927;3:93–11043.\nZondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382:1244–56. https://doi.org/10.1056/NEJMra1810764.\nWu X-G, Chen J-J, Zhou H-L, Wu Y, Lin F, Shi J, et al. Identification and validation of the signatures of infiltrating immune cells in the eutopic endometrium endometria of women with endometriosis. Front Immunol. 2021;12:671201. https://doi.org/10.3389/fimmu.2021.671201.\nMassier L, Musat N, Stumvoll M, Tremaroli V, Chakaroun R, Kovacs P. Tissue-resident bacteria in metabolic diseases: emerging evidence and challenges. Nat Metab. 2024;6:1209–24. https://doi.org/10.1038/s42255-024-01065-0.\nLaschke MW, Menger MD. The gut microbiota: a puppet master in the pathogenesis of endometriosis? Am J Obstet Gynecol. 2016;215:68.e1-68.e4. https://doi.org/10.1016/j.ajog.2016.02.036.\nWang W, Feng D, Ling B. Biologia futura: endometrial microbiome affects endometrial receptivity from the perspective of the endometrial immune microenvironment. Biol FUTURA. 2022;73:291–300. https://doi.org/10.1007/s42977-022-00134-3.\nZhong Q, Yang F, Chen X, Li J, Zhong C, Chen S. Patterns of immune infiltration in endometriosis and their relationship to r-AFS stages. Front Genet. 2021;12:631715. https://doi.org/10.3389/fgene.2021.631715.\nShao J, Zhang B, Yu J-J, Wei C-Y, Zhou W-J, Chang K-K, et al. Macrophages promote the growth and invasion of endometrial stromal cells by downregulating IL-24 in endometriosis. Reprod Bioscientifica Ltd. 2016;152:673–82.\nKeyama K, Kato T, Kadota Y, Erdenebayar O, Kasai K, Kawakita T, et al. Lipopolysaccharide promotes early endometrial-peritoneal interactions in a mouse model of endometriosis. J Med Invest. 2019;66:70–4. https://doi.org/10.2152/jmi.66.70.\nKhan KN, Kitajima M, Fujishita A, Nakashima M, Masuzaki H. Toll-like receptor system and endometriosis. J Obstet Gynaecol Res. 2013;39:1281–92. https://doi.org/10.1111/jog.12117.\nOta H, Igarashi S, Hatazawa J, Tanaka T. Endometriosis and free radicals. Gynecol Obstet Invest. 1999;48:29–35.\nEley A, Pacey AA, Galdiero M, Galdiero M, Galdiero F. Can chlamydia trachomatis directly damage your sperm? Lancet Infect Dis. 2005;5:53–7. https://doi.org/10.1016/S1473-3099(04)01254-X.\nHu Q, Lyon CJ, Fletcher JK, Tang W, Wan M, Hu TY. Extracellular vesicle activities regulating macrophage-and tissue-mediated injury and repair responses. Acta Pharm Sinica B Elsevier. 2021;11:1493–512.\nVallvé-Juanico J, Santamaria X, Vo KC, Houshdaran S, Giudice LC. Macrophages display Proinflammatory phenotypes in the eutopic endometrium of women with endometriosis with relevance to an infectious etiology of the disease. Fertility and sterility. Elsevier. 2019;112:1118–28.\nWu J, Xie H, Yao S, Liang Y. Macrophage and nerve interaction in endometriosis. J Neuroinflammation. 2017;14:53. https://doi.org/10.1186/s12974-017-0828-3.\nAlAshqar A, Reschke L, Kirschen GW, Borahay MA. Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies. Biology of reproduction. Volume 105. Oxford University Press; 2021. pp. 7–31.\nJensen AL, Collins J, Shipman EP, Wira CR, Guyre PM, Pioli PA. A subset of human uterine endometrial macrophages is alternatively activated. Am J Reprod Immunol. 2012;68:374–86. https://doi.org/10.1111/j.1600-0897.2012.01181.x.\nTakebayashi A, Kimura F, Kishi Y, Ishida M, Takahashi A, Yamanaka A, et al. Subpopulations of macrophages within eutopic endometrium of endometriosis patients. Am J Reprod Immunol. 2015;73:221–31. https://doi.org/10.1111/aji.12331.\nWickström K, Stavréus-Evers A, Vercauteren O, Olovsson M, Edelstam G. Effect of lignocaine on IL-6, IL-8, and MCP-1 in peritoneal macrophages and endometriotic stromal cells. Reprod Sci. 2017;24:382–92. https://doi.org/10.1177/1933719116657188.\nItoh F, Komohara Y, Takaishi K, Honda R, Tashiro H, Kyo S, et al. Possible involvement of signal transducer and activator of transcription-3 in cell–cell interactions of peritoneal macrophages and endometrial stromal cells in human endometriosis. Fertility Steril Elsevier. 2013;99:1705–13.\nMalyshev I, Malyshev Y. Current concept and update of the macrophage plasticity concept: intracellular mechanisms of reprogramming and M3 macrophage switch phenotype. Biomed Res Int. 2015;2015:1–22. https://doi.org/10.1155/2015/341308.\nYan S, Huang Y, Xu L, Dong X, Wang S, Jiao X, et al. Escherichia coli inhibits endometriosis by inducing M1 polarity of peritoneal macrophages and the IL-1 signaling pathway. Mol Hum Reprod. 2023;29:gaad014. https://doi.org/10.1093/molehr/gaad014.\nWaisman A, Lukas D, Clausen BE, Yogev N. Dendritic cells as gatekeepers of tolerance. Semin Immunopathol. 2017;39:153–63. https://doi.org/10.1007/s00281-016-0583-z.\nKashyap AS, Fernandez-Rodriguez L, Zhao Y, Monaco G, Trefny MP, Yoshida N, et al. GEF-H1 signaling upon microtubule destabilization is required for dendritic cell activation and specific anti-tumor responses. Cell Rep Elsevier. 2019;28:3367–80.\nLaginha PA, Arcoverde FVL, Riccio LGC, Andres MP, Abrão MS. The role of dendritic cells in endometriosis: a systematic review. J Reprod Immunol. 2022;149:103462. https://doi.org/10.1016/j.jri.2021.103462.\nQiaomei Z, Ping W, Yanjing Z, Jinhua W, Shaozhan C, Lihong C. Features of peritoneal dendritic cells in the development of endometriosis. Reprod Biol Endocrinol. 2023;21:4. https://doi.org/10.1186/s12958-023-01058-w.\nSchulke L, Berbic M, Manconi F, Tokushige N, Markham R, Fraser IS. Dendritic cell populations in the eutopic and ectopic endometrium of women with endometriosis. Hum Reprod. 2009;24:1695–703. https://doi.org/10.1093/humrep/dep071.\nSobstyl A, Chałupnik A, Mertowska P, Grywalska E. How do microorganisms influence the development of endometriosis? Participation of genital, intestinal and oral microbiota in metabolic regulation and immunopathogenesis of endometriosis. Int J Mol Sci. 2023;24:10920. https://doi.org/10.3390/ijms241310920.\nZindel J, Kubes P. DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation. Annu Rev Pathol. 2020;15:493–518. https://doi.org/10.1146/annurev-pathmechdis-012419-032847.\nHernandes C, Gueuvoghlanian-Silva BY, Monnaka VU, Ribeiro NM, Pereira WdeO, Podgaec S. Regulatory T cells isolated from endometriotic peritoneal fluid express a different number of Toll-like receptors. Einstein (Sao Paulo). 2020;18:eAO5294. https://doi.org/10.31744/einstein_journal/2020AO5294.\nKhan KN, Fujishita A, Hiraki K, Kitajima M, Nakashima M, Fushiki S, et al. Bacterial contamination hypothesis: a new concept in endometriosis. Reprod Med Biol. 2018;17:125–33. https://doi.org/10.1002/rmb2.12083.\nAzuma Y, Taniguchi F, Nakamura K, Nagira K, Khine YM, Kiyama T, et al. Lipopolysaccharide promotes the development of murine endometriosis-like lesions via the nuclear factor‐kappa B pathway. Am J Reprod Immunol. 2017;77:e12631. https://doi.org/10.1111/aji.12631.\nSobstyl M, Niedźwiedzka-Rystwej P, Grywalska E, Korona-Głowniak I, Sobstyl A, Bednarek W, et al. Toll-like receptor 2 expression as a new hallmark of advanced endometriosis. Cells. 2020;9:1813. https://doi.org/10.3390/cells9081813.\nNoh EJ, Kim DJ, Lee JY, Park JH, Kim J-S, Han JW, et al. Ureaplasma urealyticum infection contributes to the development of pelvic endometriosis through toll-like receptor 2. Front Immunol. 2019;10:2373. https://doi.org/10.3389/fimmu.2019.02373.\nRaghibi M, Raghibi M, Morovvati A, Shakib P, Aflatoonian R, Dirbaiyan A. Expression of mRNA-TLR-5 gene in patients with endometriosis using real-time PCR in Tehran, Iran. Recent Adv Antiinfect Drug Discov. 2024;19:300–6. https://doi.org/10.2174/0127724344251369231212061409.\nKawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol. 2010;11:373–84. https://doi.org/10.1038/ni.1863.\nKhan KN, Kitajima M, Hiraki K, Fujishita A, Sekine I, Ishimaru T, et al. Toll-like receptors in innate immunity: role of bacterial endotoxin and toll-like receptor 4 in endometrium and endometriosis. Gynecol Obstet Invest. 2009;68:40–52. https://doi.org/10.1159/000212061.\nMortaz E, Adcock IM, Tabarsi P, Darazam IA, Movassaghi M, Garssen J, et al. Pattern recognitions receptors in immunodeficiency disorders. Eur J Pharmacol. 2017;808:49–56. https://doi.org/10.1016/j.ejphar.2017.01.014.\nHarlev A, Gupta S, Agarwal A. Targeting oxidative stress to treat endometriosis. Expert Opin Ther Targets. 2015;19:1447–64. https://doi.org/10.1517/14728222.2015.1077226.\nDonnez J, Binda MM, Donnez O, Dolmans M-M. Oxidative stress in the pelvic cavity and its role in the pathogenesis of endometriosis. Fertil Steril. 2016;106:1011–7. https://doi.org/10.1016/j.fertnstert.2016.07.1075.\nYuan M, Li D, Zhang Z, Sun H, An M, Wang G. Endometriosis induces gut microbiota alterations in mice. Hum Reprod. 2018;33:607–16. https://doi.org/10.1093/humrep/dex372.\nEmani R, Alam C, Pekkala S, Zafar S, Emani MR, Hänninen A. Peritoneal cavity is a route for gut-derived microbial signals to promote autoimmunity in non-obese diabetic mice. Scand J Immunol. 2015;81:102–9. https://doi.org/10.1111/sji.12253.\nChadchan SB, Naik SK, Popli P, Talwar C, Putluri S, Ambati CR, et al. Gut microbiota and microbiota-derived metabolites promotes endometriosis. Cell Death Discov. 2023;9:28. https://doi.org/10.1038/s41420-023-01309-0.\nVan Langendonckt A, Casanas-Roux F, Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril. 2002;77:861–70. https://doi.org/10.1016/s0015-0282(02)02959-x.\nOta H, Igarashi S, Hatazawa J, Tanaka T. Endometriosis and free radicals. Gynecol Obstet Invest. 1999;48(Suppl 1):29–35. https://doi.org/10.1159/000052866.\nIto F, Yamada Y, Shigemitsu A, Akinishi M, Kaniwa H, Miyake R, et al. Role of oxidative stress in epigenetic modification in endometriosis. Reprod Sci. 2017;24:1493–502. https://doi.org/10.1177/1933719117704909.\nRosa CP, Belo TCA, Santos NC, de Silva M, Gasparotto EN, Corsetti J. Reactive oxygen species trigger inflammasome activation after intracellular microbial interaction. Life Sci. 2023;331:122076. https://doi.org/10.1016/j.lfs.2023.122076.\nHirata T, Osuga Y, Hirota Y, Koga K, Yoshino O, Harada M, et al. Evidence for the presence of toll-like receptor 4 system in the human endometrium. J Clin Endocrinol Metab. 2005;90:548–56. https://doi.org/10.1210/jc.2004-0241.\nKhan KN, Kitajima M, Yamaguchi N, Fujishita A, Nakashima M, Ishimaru T, et al. Role of prostaglandin E2 in bacterial growth in women with endometriosis. Hum Reprod. 2012;27:3417–24. https://doi.org/10.1093/humrep/des331.\nLiu Y, Wang J, Zhang X. An update on the multifaceted role of NF-kappaB in endometriosis. Int J Biol Sci. 2022;18:4400–13. https://doi.org/10.7150/ijbs.72707.\nLin Y-H, Chen Y-H, Chang H-Y, Au H-K, Tzeng C-R, Huang Y-H. Chronic niche inflammation in Endometriosis-Associated Infertility: current understanding and future therapeutic strategies. Int J Mol Sci. 2018;19:2385. https://doi.org/10.3390/ijms19082385.\nZdrojkowski Ł, Jasiński T, Ferreira-Dias G, Pawliński B, Domino M. The role of NF-κB in endometrial diseases in humans and animals: a review. Int J Mol Sci. 2023;24:2901. https://doi.org/10.3390/ijms24032901.\nKhan KN, Kitajima M, Inoue T, Fujishita A, Nakashima M, Masuzaki H. 17β-estradiol and lipopolysaccharide additively promote pelvic inflammation and growth of endometriosis. Reprod Sci. 2015;22:585–94. https://doi.org/10.1177/1933719114556487.\nZhao Y, Gong P, Chen Y, Nwachukwu JC, Srinivasan S, Ko C, et al. Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis. Sci Transl Med. 2015;7:271ra9. https://doi.org/10.1126/scitranslmed.3010626.\nYuan J, Dong X, Yap J, Hu J. The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy. J Hematol Oncol. 2020;13:113. https://doi.org/10.1186/s13045-020-00949-4.\nMcCubrey JA, Lahair MM, Franklin RA. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal. 2006;8:1775–89. https://doi.org/10.1089/ars.2006.8.1775.\nYoshino O, Osuga Y, Hirota Y, Koga K, Hirata T, Harada M, et al. Possible pathophysiological roles of mitogen-activated protein kinases (MAPKs) in endometriosis. Am J Reprod Immunol. 2004;52:306–11. https://doi.org/10.1111/j.1600-0897.2004.00231.x.\nSantulli P, Marcellin L, Tosti C, Chouzenoux S, Cerles O, Borghese B, et al. MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis? Expert Opin Ther Targets. 2015;19:1465–83. https://doi.org/10.1517/14728222.2015.1090974.\nMurk W, Atabekoglu CS, Cakmak H, Heper A, Ensari A, Kayisli UA, et al. Extracellularly signal-regulated kinase activity in the human endometrium: possible roles in the pathogenesis of endometriosis. J Clin Endocrinol Metab. 2008;93:3532–40. https://doi.org/10.1210/jc.2007-2051.\nNgô C, Chéreau C, Nicco C, Weill B, Chapron C, Batteux F. Reactive oxygen species controls endometriosis progression. Am J Pathol. 2009;175:225–34. https://doi.org/10.2353/ajpath.2009.080804.\nNgô C, Nicco C, Leconte M, Chéreau C, Arkwright S, Vacher-Lavenu M-C, et al. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo. J Pathol. 2010;222:148–57. https://doi.org/10.1002/path.2756.\nHung SW, Zhang R, Tan Z, Chung JPW, Zhang T, Wang CC. Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: a review. Med Res Rev. 2021;41:2489–564. https://doi.org/10.1002/med.21802.\nChadchan SB, Cheng M, Parnell LA, Yin Y, Schriefer A, Mysorekar IU, et al. Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota. Hum Reprod. 2019;34:1106–16. https://doi.org/10.1093/humrep/dez041.\nDavidson IM, Nikbakht E, Haupt LM, Ashton KJ, Dunn PJ. Methodological approaches in 16S sequencing of female reproductive tract in fertility patients: a review. J Assist Reprod Genet. 2025;42:15–37. https://doi.org/10.1007/s10815-024-03292-6.\nMiyashira CH, Oliveira FR, Andres MP, Gingold JA, Abrão MS. The microbiome and endometriosis. Reprod Fertil. 2022;3:R163-75. https://doi.org/10.1530/RAF-21-0113.\nGiudice LC, Kao LC. Endometriosis. Lancet. 2004;364:1789–99. https://doi.org/10.1016/S0140-6736(04)17403-5.\nVercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10:261–75. https://doi.org/10.1038/nrendo.2013.255.\nFunding\nThis research was supported by the Natural Science Foundation of Hubei Province (Grant No. 20181152).\nAuthor information\nAuthors and Affiliations\nContributions\nConceptualization: Yi Shen, Ziying Xu.\nWriting – Original Draft: Ziying Xu.\nWriting – Review & Editing: Ziying Xu, Weina Guo, Yi Shen.\nVisualization: Ziying Xu.\nSupervision: Yi Shen.\nFunding acquisition: Yi Shen.\nCorresponding author\nEthics declarations\nEthics approval\nThis research did not involve any human or animal subjects; therefore, IACUC (or IRB) approval was not required.\nConsent To Participate\nNot applicable.\nConsent for Publication\nNot applicable.\nCompeting Interests\nNone of the authors have any conflicts of interest to declare.\nAdditional information\nPublisher’s Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nRights and permissions\nSpringer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.\nAbout this article\nCite this article\nXu, Z., Guo, W. & Shen, Y. Advances in the Role of Endometrial Microbiota Alterations in the Pathogenesis of Endometriosis. Reprod. Sci. 33, 482–495 (2026). https://doi.org/10.1007/s43032-026-02050-6\nReceived:\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s43032-026-02050-6","source_license":"public-domain-us","license_restricted":false}